SomaLogic to provide 105 million protein measurements from 15,000 samples as part of the Multi-Ethnic Study of Atherosclerosis (MESA) Study
February 02, 2022 08:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., Feb. 02, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that the company will begin assaying samples from the...
SomaLogic Announces Preliminary Revenue for Full Year 2021 Above Guidance Range
January 11, 2022 07:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., Jan. 11, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced preliminary, unaudited revenue expectations for the year ending...
SomaLogic Announces Appointment of Adam Taich as Chief Business Officer
January 10, 2022 16:10 ET
|
SomaLogic, Inc.
BOULDER, Colo., Jan. 10, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Adam Taich has joined the company as the Chief...
SomaLogic Announces Analyst and Investor Meeting on February 4, 2022
January 07, 2022 08:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., Jan. 07, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, will host a virtual Analyst and Investor Meeting on Friday, February 4, 2022,...
SomaLogic announces exclusive partnership with Illumina to develop sequencing-based proteomic solutions
January 05, 2022 16:10 ET
|
SomaLogic, Inc.
BOULDER, Colo., Jan. 05, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a worldwide strategic collaboration with Illumina, a global...
SomaLogic to Participate in the 40th Annual J.P. Morgan Healthcare Conference
December 30, 2021 16:30 ET
|
SomaLogic, Inc.
BOULDER, Colo., Dec. 30, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the upcoming...
SomaLogic’s SomaScan® Assay used in largest proteomic study to date, bridging the gap between genomics and disease
December 09, 2021 08:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., Dec. 09, 2021 (GLOBE NEWSWIRE) -- In a new study published in Nature Genetics, scientists at deCODE genetics, a subsidiary of Amgen, used SomaLogic’s (NASDAQ: SLGC) SomaScan Assay to...
SomaLogic Announces Appointment of Steven Mermelstein as Senior Vice President of Corporate Strategy, Development and Mergers and Acquisitions
December 02, 2021 16:10 ET
|
SomaLogic, Inc.
BOULDER, Colo., Dec. 02, 2021 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Steve Mermelstein joined the company as Senior Vice...
SomaLogic Reports Third Quarter 2021 Financial Results
November 15, 2021 07:15 ET
|
SomaLogic, Inc.
Increase of 40% in third quarter revenue to $20.0 million over the corresponding period in 2020Increase of 112% in year-to-date revenue to $58.6 million over the corresponding period in 2020 Raising...
SomaLogic to Present at the Stifel 2021 Virtual Healthcare Conference
November 03, 2021 16:10 ET
|
SomaLogic, Inc.
NEW YORK and BOULDER, Colo., Nov. 03, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the...